Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$86.5 - $128.27 $3.68 Million - $5.45 Million
-42,490 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $47,207 - $59,421
463 Added 1.1%
42,490 $5 Million
Q4 2021

Feb 03, 2022

BUY
$106.37 - $130.68 $17,338 - $21,300
163 Added 0.39%
42,027 $5.45 Million
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $10,805 - $12,888
-105 Reduced 0.25%
41,864 $4.74 Million
Q2 2021

Jul 28, 2021

SELL
$83.84 - $104.76 $6,791 - $8,485
-81 Reduced 0.19%
41,969 $4.35 Million
Q1 2021

Apr 23, 2021

BUY
$78.68 - $90.67 $28,560 - $32,913
363 Added 0.87%
42,050 $3.52 Million
Q4 2020

Jan 26, 2021

BUY
$71.69 - $91.23 $111,764 - $142,227
1,559 Added 3.89%
41,687 $3.8 Million
Q3 2020

Oct 19, 2020

BUY
$67.19 - $87.44 $14,109 - $18,362
210 Added 0.53%
40,128 $3.2 Million
Q2 2020

Aug 03, 2020

BUY
$57.54 - $76.95 $1.56 Million - $2.08 Million
27,029 Added 209.71%
39,918 $2.76 Million
Q4 2019

Jan 13, 2020

SELL
$71.7 - $82.09 $35,491 - $40,634
-495 Reduced 3.7%
12,889 $3.01 Million
Q3 2019

Oct 09, 2019

BUY
$61.55 - $75.43 $307 - $377
5 Added 0.04%
13,384 $2.94 Million
Q2 2019

Jul 17, 2019

SELL
$55.74 - $64.41 $12,820 - $14,814
-230 Reduced 1.69%
13,379 $2.47 Million
Q1 2019

Apr 16, 2019

SELL
$47.89 - $64.05 $14,127 - $18,894
-295 Reduced 2.12%
13,609 $2.6 Million
Q4 2018

Jan 04, 2019

BUY
$46.41 - $56.94 $6,404 - $7,857
138 Added 1.0%
13,904 $2.13 Million
Q3 2018

Oct 12, 2018

SELL
$45.7 - $58.03 $149,256 - $189,525
-3,266 Reduced 19.18%
13,766 $2.4 Million
Q2 2018

Jul 23, 2018

BUY
$42.45 - $51.3 $3,396 - $4,104
80 Added 0.47%
17,032 $2.48 Million
Q1 2018

Apr 10, 2018

SELL
$37.19 - $47.45 $61,363 - $78,292
-1,650 Reduced 8.87%
16,952 $2.37 Million
Q4 2017

Jan 24, 2018

BUY
$33.79 - $39.39 $628,561 - $732,732
18,602
18,602 $2.1 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Tower View Investment Management & Research LLC Portfolio

Follow Tower View Investment Management & Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.